Memphasys Limited (ASX:MEM)
0.0040
0.00 (0.00%)
Oct 28, 2025, 2:59 PM AEST
Memphasys Revenue
In the fiscal year ending June 30, 2025, Memphasys had annual revenue of 526.92K AUD with 237.77% growth. Memphasys had revenue of 201.58K in the half year ending June 30, 2025, a decrease of -49.10%.
Revenue
526.92K
Revenue Growth
+237.77%
P/S Ratio
17.01
Revenue / Employee
21.96K
Employees
24
Market Cap
8.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 526.92K | 370.92K | 237.77% |
| Jun 30, 2024 | 156.00K | -468.37K | -75.01% |
| Jun 30, 2023 | 624.37K | 53.29K | 9.33% |
| Jun 30, 2022 | 571.08K | 359.60K | 170.04% |
| Jun 30, 2021 | 211.48K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |